Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,000,000 | 2,388,000 | 3,106,000 | 2,137,000 | 4,662,000 |
| Depreciation Amortization | 929,000 | 909,000 | 789,000 | 735,000 | 728,000 |
| Income taxes - deferred | -812,000 | 278,000 | 249,000 | -471,000 | -1,376,000 |
| Accounts receivable | 539,000 | -556,000 | -549,000 | 906,000 | -269,000 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | -131,000 |
| Other Working Capital | -904,000 | -600,000 | -754,000 | -2,220,000 | 3,081,000 |
| Other Operating Activity | -916,000 | 757,000 | 671,000 | -142,000 | -1,323,000 |
| Operating Cash Flow | $1,836,000 | $3,176,000 | $3,512,000 | $945,000 | $5,372,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,043,000 | -779,000 | -1,385,000 | -520,000 | -814,000 |
| PPE Investments | -665,000 | -641,000 | -878,000 | -1,048,000 | -1,139,000 |
| Net Acquisitions | 843,000 | 214,000 | N/A | 159,000 | -2,272,000 |
| Purchase Of Investment | N/A | N/A | -85,000 | -133,000 | -1,207,000 |
| Purchase Sale Intangibles | -30,000 | -137,000 | -53,000 | -78,000 | -105,000 |
| Other Investing Activity | -30,000 | -416,000 | -71,000 | -488,000 | -253,000 |
| Investing Cash Flow | $1,191,000 | $-1,622,000 | $-2,419,000 | $-2,030,000 | $-5,685,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,625,000 | 1,558,000 | -1,189,000 | 1,164,000 | 392,000 |
| Debt Issued | 2,510,000 | 15,000 | 2,286,000 | 6,000 | 4,854,000 |
| Debt Repayment | -2,502,000 | -3,000 | -3,000 | -9,000 | -3,000 |
| Common Stock Issued | 166,000 | 141,000 | 44,000 | 138,000 | 251,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -164,000 | -1,589,000 |
| Dividend Paid | -2,186,000 | -2,174,000 | -2,169,000 | -2,168,000 | -2,137,000 |
| Financing Cash Flow | $-3,637,000 | $-463,000 | $-1,031,000 | $-1,033,000 | $1,768,000 |
| Exchange Rate Effect | -20,000 | 40,000 | 36,000 | 17,000 | 12,000 |
| Beginning Cash Position | 3,680,000 | 2,549,000 | 2,451,000 | 4,552,000 | 3,085,000 |
| End Cash Position | 3,050,000 | 3,680,000 | 2,549,000 | 2,451,000 | 4,552,000 |
| Net Cash Flow | $-630,000 | $1,131,000 | $98,000 | $-2,101,000 | $1,467,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,836,000 | 3,176,000 | 3,512,000 | 945,000 | 5,372,000 |
| Capital Expenditure | -738,000 | -676,000 | -937,000 | -1,075,000 | -1,180,000 |
| Free Cash Flow | 1,098,000 | 2,500,000 | 2,575,000 | -130,000 | 4,192,000 |